文献速递腹部技术与安全US

结直肠癌患者局灶性化疗所致肝窦损伤的超声造影表现:初步经验

Contrast-Enhanced Ultrasound Imaging Features of Focal Chemotherapy-Induced Sinusoidal Injury in Patients With Colorectal Cancer: Initial Experience.
PubMed 文献 · J Ultrasound Med · 2020-07-22

本研究回顾性评估16例经病理确诊为局灶性化疗所致肝窦损伤(CSI)患者的超声造影(CEUS)特征,并与27例结直肠癌肝转移(CRLM)患者对比。局灶性CSI在动脉期多表现为不均匀等增强(87.5%),门脉期及延迟期均表现为低增强,且造影剂慢进慢退,与CRLM显著不同,有助于鉴别诊断。

要点

  • 局灶性CSI在CEUS动脉期常表现为不均匀等增强(87.5%),门脉期及延迟期均呈低增强。
  • 局灶性CSI造影剂进退均慢于CRLM:达峰时间30.5±5.6秒 vs 22.5±4.4秒,消退时间51.0±12.5秒 vs 35.0±6.2秒。
  • 动脉期不均匀等增强在局灶性CSI为87.5%,在CRLM为0%(P < .001),是重要鉴别点。

关键影像表现/征象

  • 动脉期:14例(87.5%)局灶性CSI表现为不均匀等增强,1例(6.3%)周边高增强,1例(6.3%)均匀高增强。
  • 与邻近肝实质相比,局灶性CSI初始增强时间早于肝实质者2例(12.5%),同步者9例(56.3%),晚于肝实质者5例(31.3%)。
  • 门脉期及延迟期:所有局灶性CSI病例均表现为相对于邻近肝实质的低增强。

诊断标准与关键数值

  • 动脉期不均匀等增强:局灶性CSI 87.5% vs CRLM 0%(P < .001)。
  • 初始增强时间晚于肝实质:局灶性CSI均值0.5±1.5 vs CRLM均值-1.5±1.9(P < .001)。
  • 达峰时间:局灶性CSI 30.5±5.6秒 vs CRLM 22.5±4.4秒(P < .001)。
  • 消退时间:局灶性CSI 51.0±12.5秒 vs CRLM 35.0±6.2秒(P = .002)。

临床应用与阅片要点

  • 阅片时需注意局灶性CSI在动脉期可呈不均匀等增强,门脉期及延迟期呈低增强,避免误判为CRLM。
  • 结合造影剂慢进慢退(初始增强时间晚于肝实质、达峰时间长、消退时间长)有助于与CRLM鉴别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Increasing studies have reported focal chemotherapy-induced sinusoidal injury (CSI) mimicking colorectal liver metastasis (CRLM) on imaging studies, resulting in unnecessary lobectomy. This study aimed to investigate the contrast-enhanced ultrasound (CEUS) imaging features of focal CSI.

METHODS: We retrospectively evaluated 16 patients who had a pathologic diagnosis of focal CSI and underwent CEUS between January 2013 and January 2019. The images were compared with those obtained from 27 patients with CRLM.

RESULTS: On CEUS, 14 (87.5%) focal CSIs showed heterogeneous isoenhancement, 1 (6.3%) peripheral hyperenhancement, and 1 (6.3%) homogeneous hyperenhancement during the arterial phase. Compared with the adjacent liver parenchyma, the initial enhancement time of focal CSI was earlier in 2 (12.5%), simultaneous in 9 (56.3%), and later in 5 (31.3%) patients. In the portal and late phases, all of the focal CSI cases showed hypoenhancement compared with the adjacent liver parenchyma. Focal CSI had the following CEUS findings, which were different from those of CRLM: (1) heterogeneous isoenhancement in the arterial phase (87.5% versus 0%; P < .001); (2) an initial enhancement time later than that of the liver parenchyma (mean ± SD, 0.5 ± 1.5 versus -1.5 ± 1.9; P < .001); (3) a longer time to peak (30.5 ± 5.6 versus 22.5 ± 4.4 seconds; P < .001); and (4) a later time to wash-out (51.0 ± 12.5 versus 35.0 ± 6.2 seconds; P = .002).

CONCLUSIONS: Focal CSI usually shows heterogeneous isoenhancement in arterial phase and hypoenhancement in portal and late phases on CEUS, with slow contrast wash-in and wash-out, which can be helpful in the differential diagnosis with CRLM.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Qin S, Cui R, Wang Y, et al. Contrast-Enhanced Ultrasound Imaging Features of Focal Chemotherapy-Induced Sinusoidal Injury in Patients With Colorectal Cancer: Initial Experience. J Ultrasound Med. 2020. PMID: 32697388. doi:10.1002/jum.15384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。